Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 2
2006 2
2007 4
2008 5
2009 6
2010 3
2011 1
2012 4
2013 4
2014 2
2015 6
2016 3
2017 4
2018 8
2019 6
2020 7
2021 5
2022 8
2023 8
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
The Age of Theragnostics.
Iagaru A, Jacene HA. Iagaru A, et al. Among authors: jacene ha. PET Clin. 2024 Jul;19(3):xiii. doi: 10.1016/j.cpet.2024.03.007. Epub 2024 Apr 8. PET Clin. 2024. PMID: 38594141 No abstract available.
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP.
Litton JK, Regan MM, Pusztai L, Rugo HS, Tolaney SM, Garrett-Mayer E, Amiri-Kordestani L, Basho RK, Best AF, Boileau JF, Denkert C, Foster JC, Harbeck N, Jacene HA, King TA, Mason G, O'Sullivan CC, Prowell TM, Richardson AL, Sepulveda KA, Smith ML, Tjoe JA, Turashvili G, Woodward WA, Butler LP, Schwartz EI, Korde LA. Litton JK, et al. Among authors: jacene ha. J Clin Oncol. 2023 Sep 20;41(27):4433-4442. doi: 10.1200/JCO.23.00435. Epub 2023 Jul 11. J Clin Oncol. 2023. PMID: 37433103 Free PMC article.
Neuroendocrine Tumors: Diagnostics.
Sakellis C, Jacene HA. Sakellis C, et al. Among authors: jacene ha. PET Clin. 2024 Jul;19(3):325-339. doi: 10.1016/j.cpet.2024.03.008. Epub 2024 May 6. PET Clin. 2024. PMID: 38714399 Review.
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial.
Schoenfeld JD, Hanna GJ, Jo VY, Rawal B, Chen YH, Catalano PS, Lako A, Ciantra Z, Weirather JL, Criscitiello S, Luoma A, Chau N, Lorch J, Kass JI, Annino D, Goguen L, Desai A, Ross B, Shah HJ, Jacene HA, Margalit DN, Tishler RB, Wucherpfennig KW, Rodig SJ, Uppaluri R, Haddad RI. Schoenfeld JD, et al. Among authors: jacene ha. JAMA Oncol. 2020 Oct 1;6(10):1563-1570. doi: 10.1001/jamaoncol.2020.2955. JAMA Oncol. 2020. PMID: 32852531 Free PMC article. Clinical Trial.
PET Imaging for Hematologic Malignancies.
Hughes NM, Jacene HA. Hughes NM, et al. Among authors: jacene ha. Radiol Clin North Am. 2021 Sep;59(5):705-723. doi: 10.1016/j.rcl.2021.05.003. Radiol Clin North Am. 2021. PMID: 34392914 Review.
Imaging for Radiation Planning in Breast Cancer.
Sakellis CG, Jacene HA. Sakellis CG, et al. Among authors: jacene ha. Semin Nucl Med. 2022 Sep;52(5):542-550. doi: 10.1053/j.semnuclmed.2022.03.003. Epub 2022 May 3. Semin Nucl Med. 2022. PMID: 35523601 Review.
Interim FDG-PET/CT for Response Assessment of Lymphoma.
Zeman MN, Akin EA, Merryman RW, Jacene HA. Zeman MN, et al. Among authors: jacene ha. Semin Nucl Med. 2023 May;53(3):371-388. doi: 10.1053/j.semnuclmed.2022.10.004. Epub 2022 Nov 12. Semin Nucl Med. 2023. PMID: 36376131 Review.
Gynecologic oncologic imaging with PET/CT.
Grant P, Sakellis C, Jacene HA. Grant P, et al. Among authors: jacene ha. Semin Nucl Med. 2014;44(6):461-78. doi: 10.1053/j.semnuclmed.2014.06.005. Semin Nucl Med. 2014. PMID: 25362236 Review.
83 results